Loprinzi CL - Search Results

1

Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†.

Renfro LA, Grothey A, Kerr D, Haller DG, André T, Van Cutsem E, Saltz L, Labianca R, Loprinzi CL, Alberts SR, Schmoll H, Twelves C, Yothers G, Sargent DJ; Adjuvant Colon Cancer Endpoints (ACCENT) Group. Renfro LA, et al. Among authors: loprinzi cl. Ann Oncol. 2015 May;26(5):950-958. doi: 10.1093/annonc/mdv073. Epub 2015 Feb 19. Ann Oncol. 2015. PMID: 25697217 Free PMC article.

2

Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer.

Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Camoriano JK, et al. Among authors: loprinzi cl. J Clin Oncol. 1990 Aug;8(8):1327-34. doi: 10.1200/JCO.1990.8.8.1327. J Clin Oncol. 1990. PMID: 2199619 Clinical Trial.

3

Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer.

Loprinzi CL, Kuross SA, O'Fallon JR, Gesme DH Jr, Gerstner JB, Rospond RM, Cobau CD, Goldberg RM. Loprinzi CL, et al. J Clin Oncol. 1994 Jun;12(6):1121-5. doi: 10.1200/JCO.1994.12.6.1121. J Clin Oncol. 1994. PMID: 8201373 Clinical Trial.

4

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.

Loprinzi CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW, Jett JR, Ghosh C, Pfeifle DM, et al. Loprinzi CL, et al. J Clin Oncol. 1994 Jun;12(6):1126-9. doi: 10.1200/JCO.1994.12.6.1126. J Clin Oncol. 1994. PMID: 8201374 Clinical Trial.

5

An evaluation of postoperative follow-up tests in colon cancer patients treated for cure.

Peethambaram P, Weiss M, Loprinzi CL, Novotny P, O'Fallon JR, Erlichman C, O'Connell MJ, Laurie JA. Peethambaram P, et al. Among authors: loprinzi cl. Oncology. 1997 Jul-Aug;54(4):287-92. doi: 10.1159/000227705. Oncology. 1997. PMID: 9216852

6

History of the development of antiemetic guidelines at Mayo Clinic Rochester.

Loprinzi CL, Alberts SR, Christensen BJ, Hanson LJ, Farley DR, Broers JK, Betcher DL, Grady RE, Southorn PA, Johnson TM, Perez EA. Loprinzi CL, et al. Mayo Clin Proc. 2000 Mar;75(3):303-9. doi: 10.4065/75.3.303. Mayo Clin Proc. 2000. PMID: 10725961 Review.

7

Understanding the utility of adjuvant systemic therapy for primary breast cancer.

Loprinzi CL, Thomé SD. Loprinzi CL, et al. J Clin Oncol. 2001 Feb 15;19(4):972-9. doi: 10.1200/JCO.2001.19.4.972. J Clin Oncol. 2001. PMID: 11181659

8

Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer.

Sloan JA, Goldberg RM, Sargent DJ, Vargas-Chanes D, Nair S, Cha SS, Novotny PJ, Poon MA, O'Connell MJ, Loprinzi CL. Sloan JA, et al. Among authors: loprinzi cl. J Clin Oncol. 2002 Mar 15;20(6):1491-8. doi: 10.1200/JCO.2002.20.6.1491. J Clin Oncol. 2002. PMID: 11896096

9

A phase II study of topical ceramides for cutaneous breast cancer.

Jatoi A, Suman VJ, Schaefer P, Block M, Loprinzi C, Roche P, Garneau S, Morton R, Stella PJ, Alberts SR, Pittelkow M, Sloan J, Pagano R. Jatoi A, et al. Breast Cancer Res Treat. 2003 Jul;80(1):99-104. doi: 10.1023/A:1024409123726. Breast Cancer Res Treat. 2003. PMID: 12889603 Clinical Trial.

10

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM. Gill S, et al. Among authors: loprinzi cl. J Clin Oncol. 2004 May 15;22(10):1797-806. doi: 10.1200/JCO.2004.09.059. Epub 2004 Apr 5. J Clin Oncol. 2004. PMID: 15067028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

514 results

Search Page